2015

Renewed attention for investigator-initiated trials

Tuesday, December 15, 2015

After a five- to eight-year decline, investigator-initiated trials (IITs) are gaining renewed interest as more biopharmaceutical companies are using them as a creative and cost-effective way to innovate and further improve patient safety.

[Read More]

Bracket adds SMS messaging to RTSM platform

Monday, December 14, 2015

Bracket, a Wayne, Pa.-based clinical trial specialty services provider, has announced a new update to its Randomization and Trial Supply Management product. Mobile patient reminders, delivered via SMS text messaging, now are available as a core component of Bracket’s RTSM 4.0 platform.

[Read More]

FDA approves emergency treatment for chemotherapy overdoses

Monday, December 14, 2015

The FDA has approved Vistogard (uridine triacetate) for the emergency treatment of adults and children who receive an overdose of the cancer treatment fluorouracil or capecitabine, or who develop certain severe or life-threatening toxicities within four days of receiving those cancer treatments.

[Read More]